Relation between estrogen receptor status and response to oophorectomy in advanced breast cancer
Cappelletti, V.; Coradini, D.; Miodini, P.; Oriana, S.; Bohm, S.; Sasso, G.M.; D.F.onzo G.
Breast Cancer Research and Treatment 8(1): 90
1986
ISSN/ISBN: 0167-6806
Accession: 029064882
PDF emailed within 1 workday: $29.90
Related References
Jonat, W.; Maass, H.; Stolzenbach, G.; Trams, G. 1980: Estrogen receptor status and response to polychemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2809-2813Kiang, D.T.; Frenning, D.H.; Gay, J.; Goldman, A.I.; Kennedy, B.J. 1980: Estrogen receptor status and response to chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2814-2817
Bonadonna, G.; Valagussa, P.; Tancini, G.; Di Fronzo, G. 1980: Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer Cancer ChemoTherapy and Pharmacology 4(1): 37-41
Stewart, J.F.; Hayward, J.L.; Rubens, R.D.; King, R.J. 1982: Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for response Cancer ChemoTherapy and Pharmacology 9(2): 124-125
Rosner, D.; Nemoto, T.; Lane, W.W. 1988: Response to chemotherapy in metastatic breast cancer in relation to estrogen receptor status Proceedings of the American Association for Cancer Research Annual Meeting 29: 197
Paridaens, R.; Leclercq, G.; Heuson, J.C. 1984: Estrogen receptor status and the clinical response to a combination of aminoglutethimide and cortisol in advanced breast cancer Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 91: 248-252
Fernández-Morales, L.A.; Seguí, M.A.; Andreu, X.; Dalmau, E.; Sáez, A.; Pericay, C.; Santos, C.; Montesinos, J.ús.; Gallardo, E.; Arcusa, A.; Saigí, E. 2007: Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status Clinical Breast Cancer 7(7): 559-564
Rosenbaum, C.; Marsland, T.A.; Stolbach, L.L.; Raam, S.; Cohen, J.L. 1980: Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience Cancer 46(12 Suppl): 2919-2921
Paradiso, A.; Tommasi, S.; Mangia, A.; Lorusso, V.; Simone, G.; De Lena, M. 1990: Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer Cancer Research 50(10): 2958-2962
Preda, F.; Pizzocaro, G.; Oriana, S.; Riboldi, G.; Severini, A.; Di Fronzo, G.; Secreto, G.; Grattarola, R. 1979: Correlation between clinical response to bilateral oophorectomy, estrogen receptors and urinary androgen excretion in 49 patients with advanced breast cancer Tumori 65(3): 325-330
Nomura, Y.; Abe, Y.; Inokuchi, K. 1974: Specific estrogen receptor and its relation to response to oophorectomy in rat mammary cancer induced by 7,12-dimethylbenz[a]anthracene Gan 65(6): 523-528
Love, R.R.; Duc, N.B.; Havighurst, T.C.; Mohsin, S.K.; Zhang, Q.; DeMets, D.L.; Allred, D.C. 2003: Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(3): 453-457
Normura, Y.; Yamagata, J.; Katayama, K.; Yoshitani, N.; Tanaka, M. 1980: Reevaluation of clinical parameters in relation to estrogen receptor assay in predicting response to major endocrine ablation therapy in patients with advanced breast cancer Japanese Journal of Clinical Oncology 10(1): 61-68
Monnier, A.; Sun, Y.; Gershanovich, M.; Perez Carrion, R.; Chaudri Ross, H.A.; Lang, R. 2002: Time to progression and tumor response according to estrogen receptor status in the international phase III study of letrozole and tamoxifen as first-line hormonal therapy for advanced breast cancer Breast Cancer Research and Treatment 76(Suppl 1): S74
Berns, E.M.J.J.; Klijn, J.G.M.; Look, M.P.; Grebenchtchikov, N.; Vossen, R.; Peters, H.; Geurts-Moespot, A.; Portengen, H.; van Staveren, I.L.; Meijer-van Gelder, M.E.; Bakker, B.; Sweep, F.C.G.J.; Foekens, J.A. 2003: Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(4): 1253-1258